ArticleJournal of Brown hospital medicine2025
Persistent Urticaria Heralding the Onset of Bullous Pemphigoid.
Article in Journal of Brown hospital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bullous pemphigoid is a common autoimmune blistering disorder that predominantly affects older adults aged 65 and older. While most cases present with a tense blistering eruption, characteristic of the disease, there is a lesser-known pre-bullous phase of the condition that can present insidiously with urticaria and intense pruritus, which can last for several weeks or months. Failure to consider this entity in patients with treatment-refractory, persistent urticaria or itch may lead to delayed diagnosis and poor quality of life. We describe a case of a 79-year-old gentleman who presented with a 3-week history of generalized urticaria on a background of intense pruritus for 4 months. His diagnosis was eventually clinched when he developed blistering lesions on an urticated base, with serum indirect immunofluorescence demonstrating anti-basement membrane zone IgG antibodies. He was commenced on immunomodulatory treatment with moderate doses of oral corticosteroids and doxycycline, with good clinical recovery thereafter. This case vignette highlights several learning points pertaining to the recognition and management of patients with urticarial manifestations in the pre-bullous phase of this common autoimmune blistering disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.